Skip to search formSkip to main contentSkip to account menu

CGX-1007

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
CGX-1007 prevents excitotoxic cell death via actions at multiple types of NMDA receptors.
2009
2009
Studies on neuronal apoptoisis in primary forebrain cultures: Neuroprotective/anti-apoptotic action of NR2B NMDA antagonists
While the role of apoptosis in neuronal injury is continually being re-defined, approaches to intervene in the progression of… 
2005
2005
Effects of delayed intrathecal infusion of an NMDA receptor antagonist on ischemic injury and peri-infarct depolarizations
2004
2004
The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on NMDA receptor-mediated EPSCs
2004
2004
The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on kindling acquisition and expression
2003
2003
Treatment with the snail peptide CGX-1007 reduces DNA damage and alters gene expression of c-fos and bcl-2 following focal ischemic brain injury in rats
Delayed cell death following ischemic brain injury has been linked to alterations in gene expression. In this study we have… 
Review
2002
Review
2002
Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI)
Review
2002
Review
2002
Novel anticonvulsant medications in development
Epilepsy is currently the most prevalent neurological disorder worldwide. Pharmacological therapy remains the cornerstone of… 
2002
2002
Neuroprotection Profile of the High Affinity NMDA Receptor Antagonist Conantokin-G
Abstract : Conantokin-G (Con-G or CGX-1007), a potent NR2B subunit selective NMDA receptor antagonist, was evaluated for its… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)